聯成化科 UPC Technology

聯成化科 UPC Technology 我們是全球最大的 苯酐 與 可塑劑 供應商,從建築、汽車到生活用品,透過化學讓世界更有彈性~

2026Q2 UPC Investor Conference 法人說明會Q&A Session 問答集 (請往下滑到中文內容)1. Looking ahead to Q2 and the second half of the year, h...
28/05/2026

2026Q2 UPC Investor Conference 法人說明會

Q&A Session 問答集 (請往下滑到中文內容)

1. Looking ahead to Q2 and the second half of the year, how does UPC view the company’s operational outlook?

maintains a cautious but strategically flexible view toward operations in the second quarter and the second half of the year. Since May, the cancellation of export tax rebates and the end of pre-stocking driven by the conflict have led downstream customers to enter a destocking phase. In addition, June to August is traditionally the low season for the industry, resulting in a structural slowdown in demand.

However, with global peers maintaining low operating rates of around 50% to 60%, and with a significant increase in upstream alcohol feedstock capacity, spreads are expected to gradually widen. As a result, second-quarter performance is expected to be better than the same period last year.

In addition, as the Mainland Chinese government is expected to conduct energy-efficiency inspections and gradually reduce or eliminate high-energy-consuming carbide-based PVC plants in 2026, this is expected to create a structurally positive development for ethylene-based PVC producers such as UPC over the medium to long term.

Looking into the second half, amid uncertainties such as inflation, the Company will adopt the principle of determining production volume based on maintaining spreads, while responding to market changes through diversified raw material sourcing and product allocation among affiliated companies.

2. The company presentation highlighted high-end application markets. Could you further elaborate on the target industries and application segments you are focusing on?

The core strategy for high-end application markets is to reduce overreliance on traditional bulk industries, such as construction and infrastructure, and gradually shift products toward higher-quality, performance-specific demand areas, including medical devices, high-end food packaging, and automotive electronic materials.

Through frontline visits jointly conducted by R&D colleagues and the sales team, the Company aims to directly identify downstream customer pain points. At the same time, UPC can leverage its regional production and dispatch flexibility across multiple bases in Taiwan, Mainland China, and Malaysia to deepen customer relationships.

3. UPC has been strengthening its and product lines. How does the company plan to further expand in the U.S., European, and Japanese markets? Which application markets are we targeting in these regions?

In line with the environmental trend in Mainland China, where traditional plasticizers such as have been included in the List of Priority Control Chemicals, UPC is focusing on medical, high-end packaging, and automotive markets, including electric vehicle interiors.

At this stage, due to the weak economic environment and higher selling prices in Europe and the U.S., customers have shown relatively lower willingness to switch to environmentally friendly hydrogenated products such as DINCH, and progress has been somewhat slower. Therefore, the Company is currently using DINP, which has a cost advantage, as the main product for replacing traditional plasticizers. In Japan, UPC’s DINP sales have already increased significantly as local peers reduced production and exited the market.

Going forward, as the economy improves and regulations become stricter, DINCH is expected to have significant growth potential in high-end markets such as Europe, the U.S., and Japan.

4. The recovery of U.S. manufacturing and improving real estate market conditions are expected to support growth in PVC demand.

UPC fully agrees that the return of U.S. manufacturing and the recovery of the real estate market are important drivers of global PVC demand growth. However, for Asian producers, including those in Mainland China, the benefits have not yet been substantially reflected at this stage. This is mainly because carbide-based PVC still accounts for more than 70% of Mainland China’s PVC production, and its low pricing continues to create heavy export pressure on Asian PVC markets.

Recorded by: Meeting Host and Spokesperson, August Chang
Assistant Recorder: Ray Chang

https://youtu.be/nCn1qJ0Ipmg?si=MgLoNaKWYtGFKeTY

1. 展望Q2及下半年,聯成怎麼看公司營運?

#聯成 對第二季及下半年營運抱持審慎且具策略彈性的態度,雖然5月起,因取消出口退稅與戰時提前拉貨效應結束,而進入下游去庫存階段,加上6至8月為石化傳統淡季,導致需求結構性減緩。

但受惠於全球同業維持五到六成低開工率,以及上游醇類原料產能大增,預期 #可塑劑 利差將逐步擴大,使第二季表現應較去年同期為佳。

另外,隨著中國大陸政府預計於2026年,對高耗能電石法工廠進行節能監察與減產淘汰,中長期將對聯成等乙烯法廠商迎來結構性的正面利多。

而面對下半年通膨等不確定因素,公司將採取「以保持利差來決定產量」的原則,並透過原料多元化與關聯企業產品調度等方式,因應市況的變化。

2. 公司簡報中強調的高端應用市場,麻煩具體說明聚焦產業應用方向。

高端應用市場的策略核心在於降低對傳統建築與基礎建設等,大宗單一產業的過度依賴,逐步將產品轉向醫療器材、高端食品包裝以及車用電子材料等高質化、特定高性能的需求領域,並透過研發同仁第一線協同業務拜訪,直接切入下游痛點,同時發揮在台灣、中國大陸、馬來西亞等多基地的區域生產調度彈性,深化與客戶的連結度。

3. 聯成強化DINP跟DINCH,公司預計如何執行增加歐、美、日?針對這些區域我們聚焦那些市場?

順應中國大陸將傳統可塑劑如DEHP等,列入優先控制化學品名錄的環保趨勢,聯成聚焦於醫療、高端包裝及電動車內飾等車用市場。

現階段考量環保氫化產品DINCH在歐美因經濟不佳與高售價,導致客戶轉換意願較低、進展稍慢,因此公司採取以成本具備優勢的DINP作為替代傳統可塑劑的推廣主力,目前日本市場已因當地同行減產退出而促使聯成DINP銷量明顯增長。

未來隨經濟好轉與法規收緊,DINCH在歐美日等高端市場仍具備極大的發展空間。

4. 美國製造業回歸,房地產市場增溫,這是PVC需求成長原因。

聯成完全認同美國製造業回歸與房地產回溫,是拉動全球PVC需求成長的重要因素,但對於亞洲,如中國大陸的生產廠家而言,現階段尚未能實質受惠,主因是大陸電石法PVC產量仍佔七成以上,且在價格便宜,導致亞洲PVC外銷賣壓沉重。

記錄人:主持任暨發言人 張嘉麟
助理記錄人:張仕叡

In Q2 2025, the global petrochemical industry continues to face challenges such as high costs, weak demand, low-price competition, and difficulties in cost p...

我第一次與孫運璿先生碰面應是1978年,當時他剛接行政院長,我在榮總病床邊與他交流,內容大致是石化、電腦與台灣的下一步...原文請見留言處~
26/05/2026

我第一次與孫運璿先生碰面應是1978年,當時他剛接行政院長,我在榮總病床邊與他交流,內容大致是石化、電腦與台灣的下一步...

原文請見留言處~

聯華神通集團董事長苗豐強,是被孫運璿的產業政策吸引回台的創業者。1978年,他在榮總病房與孫運璿暢談近兩小時,那場對話讓他看見一位工程師出身、毫無私心的領導者,也從此影響他往後數十年的每個重大決策。以下是.....

115年股東常會|總經理致股東報告 2026 Annual Shareholders’ Meeting | President’s Report to ShareholdersIn 2025, the global chemical ind...
26/05/2026

115年股東常會|總經理致股東報告
2026 Annual Shareholders’ Meeting | President’s Report to Shareholders

In 2025, the global chemical industry continued to face multiple challenges, including geopolitical instability, fluctuations in oil and freight costs, and changes in U.S. tariff policies. Mainland China remains in a period of economic adjustment, with weak domestic demand and a slow recovery in the real estate sector continuing to weigh on overall market confidence.

For -related industries, including pipes, films, flooring, and , downstream demand has remained under pressure. Meanwhile, severe overcapacity and intense price competition in Mainland China have led to price inversions between certain products and raw materials, significantly compressing margins and creating major operational challenges.

In response to the changing external environment, has continued to strengthen production-sales coordination and pricing management, while flexibly adjusting its product portfolios and supply strategies in line with market conditions. Internally, the company has accelerated its digital transformation by introducing visualization-based decision-support tools and AI applications to improve operational efficiency and preventive maintenance capabilities. Also, UPC continues optimizing organizational structures while strengthening talent development and retention initiatives.

From a marketing perspective, UPC has also continued deepening customer engagement by restructuring industry segmentation and customer strategies, while integrating RD teams more closely into customer interactions. By jointly visiting customers alongside the sales team, UPC aims to provide more comprehensive one-stop technical and product services.

Although the external environment remains challenging, UPC significantly reduced its losses in 2025 compared with the previous year, though it has not yet returned to profitability. Looking ahead, the company will continue to uphold prudent, steady operating principles by optimizing production-sales allocation. UPC will continue to carefully adjust product portfolios, differentiate market strategies, and reduce inventory levels in line with market conditions. Through flexible operational strategies and continuous management improvements, the company aims to mitigate risks from market volatility and steadily improve business performance in the coming year.

114 年,全球 #化工產業 持續面臨地緣政治不穩定、油價與運費波動以及美國關稅政策變化等多重挑戰。中國大陸仍處於經濟調整階段,內需與房地產市場尚未明顯復甦,投資信心偏弱,整體產業景氣仍承受壓力。

對 PVC 相關產業而言,包含管材、薄膜、地板與 #可塑劑 等下游市場需求皆持續承壓,加上中國大陸產能過剩與激烈價格競爭,使部分產品與原料出現價格倒掛,毛利空間受到壓縮,對企業經營形成嚴峻挑戰。

面對外部環境變化, #聯成化科 持續強化產銷與定價管理,依市場狀況彈性調整產品組合與供應策略。在內部,公司積極推動數位化轉型,導入視覺化決策輔助工具與 AI 應用,提升營運效率與設備預防保養能力;在人才與組織方面,也同步進行制度優化,落實人才培育與留才規劃。

在行銷方面, #聯成 亦持續深化市場與客戶連結,重新梳理產業別與客戶結構,並將研發團隊導入市場端,與業務共同拜訪客戶,提供更即時且完整的一站式技術與產品服務。

儘管外部環境仍充滿挑戰,114 年公司雖未能取得獲利,虧損已較前一年大幅改善。展望 115 年,聯成化科仍將秉持審慎穩健的經營原則,以最適化產銷配置,不追求多產多銷;並視市場情況,審慎調整產品組合、區隔不同市場,同時降低庫存。透過彈性經營策略與持續精進管理,降低市場波動風險,穩步改善經營成果,期盼在 115 年交出更好的成績單。

#石化產業 #塑化產業

During  ,   had the pleasure of reconnecting with our long-term partner,  , in Shanghai!😍During the exhibition, Aaron, t...
15/05/2026

During , had the pleasure of reconnecting with our long-term partner, , in Shanghai!😍

During the exhibition, Aaron, the managing director from ALAC, invited the UPC sales team to enjoy an authentic and refined Shanghai-style dinner. As a Shanghai local, he shared many interesting stories about the city, creating a relaxed and enjoyable atmosphere throughout the evening. From industry topics and market trends to history and daily life, we truly talked about everything.

Both sides also exchanged views on recent developments in the North American market, as well as the demand and application trends for plasticizer products.

UPC shared the promotion direction of for applications such as wires and cables, while also discussing how U.S.- Iran War relations are influencing the market. From products to market trends, there were many valuable insights and ideas shared between both teams.

For UPC, meeting with a long-term partner is more than just a business discussion. It feels like reconnecting with old friends. We truly enjoyed this opportunity to catch up together!

Chinaplas2026 期間,聯成與多年合作夥伴 ALAC 在上海相聚交流!

展會期間,ALAC 總經理 魏鼎 邀請 聯成業務團隊一同享用精緻的上海菜。身為上海人的他,也分享了許多有趣的在地小故事,讓整個晚餐氣氛更加輕鬆愉快。大家從產業、市場,一路聊到歷史與生活,真的是天南地北什麼都聊。

雙方也交流了近期北美市場的變化,以及增塑劑產品的需求與應用方向。其中,我們也分享了 在電線電纜等產業的推廣應用,並針對美伊戰爭對市場帶來的影響交換看法。從產品到市場趨勢,彼此都有許多新的觀察與想法可以交流。

對聯成來說,與合作多年的夥伴見面,不只是工作上的交流,更像是老朋友之間的相聚。這次的見面,我們都非常開心!

#聯成化科

115年股東常會將於05/26召開2026 Shareholder's Meeting will be held on May 26th 根據我司03/06公告之重訊,聯成化科將於05/26 (週二) 上午09:00於總部-聯華神通大樓(南...
12/05/2026

115年股東常會將於05/26召開
2026 Shareholder's Meeting will be held on May 26th

根據我司03/06公告之重訊,聯成化科將於05/26 (週二) 上午09:00於總部-聯華神通大樓(南港區南港路1段209號)B棟一樓的國際會議廳舉行。

歡迎股東與媒體先進現場或線上參與,股東可以持股通回條,於現場提問;媒體朋友(非股東)如有想法,可以在兩天後的法人說明會提出。

有興趣參與股東會/法說會的媒體朋友,請來信報名:
投資人聯絡窗口 [email protected]
我們會有專人與您聯繫,並提供進一步資訊!

重要日期:
1. 05/26 09:00 股東常會 Annual General Shareholders' Meeting
2. 05/28 14:00 法人說明會 Investor Conference

✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿✿

According to the material information announced by UPC Technology on March 6, the Annual General Shareholders’ Meeting will be held at 9:00 a.m. on Tuesday, May 26, at the International Conference Hall, 1F, Building B, MiTAC-SYNNEX Building Headquarters (No. 209, Sec. 1, Nangang Rd., Nangang Dist., Taipei City).

Shareholders and media friends are welcome to participate either in person or online. Shareholders may raise questions on-site with their shareholder meeting notice. Media friends (who are not shareholders) are also welcome to share their thoughts during the Investor Conference to be held two days later.

Media friends interested in attending are welcome to register via email:
Investor Relations Contact ( [email protected] )
Our team will contact you directly and provide further information.

Important Dates:
05/26 09:00 Annual General Shareholders’ Meeting
05/28 14:00 Investor Conference

#股東常會 #股東大會 #股東會 #法人說明會 #法說會

During Chinaplas, we had the pleasure of meeting Romina, a lively and charismatic procurement representative from Chile....
04/05/2026

During Chinaplas, we had the pleasure of meeting Romina, a lively and charismatic procurement representative from Chile. Her company is headquartered in Santiago, and the journey to Shanghai took her nearly two days, a truly demanding trip.

Romina shared her perspective on the importance of sourcing in Asia, as well as her trust in ’s product and service quality. She mentioned that in the past, she had encountered cases where products did not meet specifications, and even situations where inferior materials were mixed and sold as higher-quality ones. While such issues can occur in the market, UPC places great importance on its reputation and always communicates transparently, providing customers with a strong sense of reliability and trust.

Romina’s engaging personality made the entire conversation lively and enjoyable. She also told us that the day (4/23) we met happened to be her birthday. We were delighted to share that moment with her and made a small wish together, that one day she will visit Taiwan and experience UPC’s headquarters in person.

Chinaplas 展會期間,我們在展場與 Romina 見面。她是來自智利、個性活潑瀟灑的採購代表,公司總部位於聖地牙哥。從當地飛到上海,足足花了兩天時間,實在相當辛苦。

會談中,Romina 提到在亞洲採購的重要性,也分享了她對聯成產品與服務品質的信任。她曾在市場上採購時,遇過規格不符,甚至以劣充優的情況。這確實是業界偶有發生的問題,而 #聯成 一向珍惜自身商譽,秉持有一說一的原則,為客戶帶來最大的安心與信任。

健談的 Romina,讓整場交流過程充滿話題與趣味。她也提到,與我們見面的當天正好是她的生日。我們很開心能在這樣特別的日子相遇,也一起許下了一個小小的心願,希望有一天她能造訪台灣,親自來到聯成總部!

From Raw Materials to Medical Safety |   and   Deepen Long-Term PartnershipLast September, invited one of our key custom...
17/04/2026

From Raw Materials to Medical Safety | and Deepen Long-Term Partnership

Last September, invited one of our key customers, to visit our Taipei headquarters, providing an opportunity for in-depth exchanges between senior management teams. Bain Medical specializes in blood purification devices and holds a leading position in the global market. Starting as a medical product trading company, Bain has evolved into a manufacturer with cross-regional production capabilities and continues to strengthen its global footprint to support worldwide demand. Its core products include hemodialysis-related consumables such as bloodlines and fistula needles, primarily based on PVC materials combined with various plasticizers to meet regulatory and application requirements across different markets.

This visit highlighted the long-standing and stable partnership between and . Bain expressed strong recognition of UPC’s quality management and group-level operational capabilities. Both parties continue to engage in ongoing discussions regarding raw material supply and application needs, aiming to identify optimal collaboration models across different regional markets to enhance supply efficiency and overall competitiveness. As the medical industry advances toward higher standards and increased automation, European and American markets are gradually shifting toward solutions, where UPC’s play a critical role. Meanwhile, Asia and other regions maintain more diversified applications, with continuously rising expectations for quality and certification.

In blood purification and high-precision infusion systems, low extractables are a key factor in ensuring treatment purity. UPC’s ® DINCH ( ) offers excellent chemical inertness and low migration properties, effectively minimizing the risk of chemical substances leaching into fluids such as blood or pharmaceutical solutions. This ensures that materials remain safe and stable even under prolonged contact with the human body, providing a reliable and high-performance solution for medical-grade PVC applications.

UniHydro® DINCH (UN899) has been developed in compliance with and GB/T 16886 biocompatibility standards, supporting the development of global Class III medical devices. By combining Bain Medical’s expertise in blood purification technologies with UPC’s strict control at the raw material level, both parties ensure the safety and stability of materials in real-world medical applications, delivering safer and more reliable treatment solutions for patients.

從材料源頭守護醫療安全 | 聯成化科與貝恩醫療深化長期夥伴關係

去年九月, #聯成化科 邀請集團重要客戶—— #貝恩醫療 蒞臨台北總部參訪,促進雙方管理層之間的深入交流。貝恩醫療專注於血液淨化設備製造,在全球市場具備領先地位。自醫療產品貿易起家,貝恩逐步發展為具備跨區域製造能力的企業,並持續強化海外布局以支援全球需求。其核心產品涵蓋血液透析相關耗材,如血路管與穿刺針等,產品結構以 PVC 材料為主,並搭配不同類型的增塑劑,以符合各地法規與應用需求。

此次交流,充分展現聯成化科與貝恩醫療長期穩定的合作關係。貝恩對聯成在品質管理與集團化運營上的表現高度肯定,雙方亦持續就原料供應與應用需求進行交流,尋求在不同區域市場中的最佳合作模式,以提升供應效率與整體競爭力。隨著醫療產業朝向更高標準與自動化發展,歐美市場逐步轉向 #非鄰苯類產品,我司的 #高端可塑劑 在此趨勢中扮演關鍵角色;而亞洲及其他地區則仍維持多元應用,對品質與認證的要求亦持續提升。

在血液淨化與高精密輸液系統中,材料的「低萃取性」是確保治療純淨度的關鍵因素。聯成化科推出的 ® DINCH ( ) 具備優異的化學惰性與低遷移特性,能有效降低化學物質析出至藥液或血液中的風險,確保材料在與人體長期接觸的環境下仍維持安全與穩定,為醫用 PVC 提供兼具性能與安全性的材料選擇。

UniHydro® DINCH (UN899) 已符合 與 GB/T 16886 等生物相容性評估標準,能穩定支持全球第三類(Class III)醫療器械的應用開發。結合貝恩醫療在血液淨化設備領域的技術優勢,以及聯成在原料端的嚴格品質把關,雙方共同確保醫療材料於實際應用中的安全性與穩定性,為患者提供更純淨且可靠的治療保障。

REACH SVHC Compliance AnalysisUnder the framework of the European Union's   regulation, Substances of Very High Concern ...
14/04/2026

REACH SVHC Compliance Analysis

Under the framework of the European Union's regulation, Substances of Very High Concern ( ) are substances that pose significant risks to human health or the environment. Once a substance is added to the Candidate List, relevant enterprises are legally mandated to fulfill compliance obligations, including information disclosure and notification.

SVHC Identification Criteria
SVHC identification criteria are established by the European Chemicals Agency ( ) through scientific assessment and review under the REACH Regulation. The list primarily covers the following types of substances:
• Substances: Carcinogenic, Mutagenic, or toxic to Reproduction.
• Substances: Persistent, Bioaccumulative, and Toxic.
• Substances: Very Persistent and Very Bioaccumulative.
• Other Substances: Substances with evidence of an equivalent level of concern.

If an assessment determines that the risks require further control, the substance may be added to the Authorisation List (Annex XIV). In such cases, companies must obtain official authorization before they can continue using the substance in the EU market.

As of March 2026, the SVHC Candidate List has been updated to the 34th batch, containing a total of 253 substances.

Phthalates (16P) in the SVHC List
Currently, the Candidate List includes 16 . Most have been categorized as SVHCs due to their reproductive toxicity or potential health risks. These substances are a primary focus for enterprises managing product compliance.

As highlighted in our previous post last week, the phthalates listed in the SVHC List fall under low-molecular-weight (hashtag ) Phthalates. In contrast, hashtag high-molecular-weight (hashtag ) Phthalates, such as DINP, DIDP, and DPHP, are generally regarded as lower-risk alternatives due to their higher molecular weight and favorable safety profiles.

Corporation stays ahead of market trends and global regulatory developments, focusing on delivering high-quality, safer material solutions and building sustainable value with our partners worldwide.

Author:
Dr. TC Wu | RD Supervisor | Group Research and Development Center

歐盟高度關注物質SVHC合規解析

在歐盟《REACH》法規框架下,高度關注物質(Substances of Very High Concern, SVHC) 係指對人類健康或環境具有重大風險的化學物質。一旦某物質被納入「候選清單」(Candidate List),相關企業即須依法履行資訊揭露與通報等合規義務。

SVHC認定標準
由歐洲化學總署(ECHA)依據REACH法規進行科學評估與審查,主要涵蓋以下類型物質:
• CMR 物質:具致癌性、致突變性或生殖毒性
• PBT 物質:具持久性、生物累積性及毒性
• vPvB 物質:具高度持久性及高度生物累積性
• 其他具同等危害證據之物質
若經評估認定其風險需進一步管制,該物質可能被納入授權清單(Authorisation List, Annex XIV),企業須取得官方授權後,方可於歐盟市場持續使用。

截至2026年3月,SVHC候選清單已更新至第34批,累計收錄253項物質。

SVHC清單中的鄰苯類物質 (即16P)
目前候選清單中共包含16項 #鄰苯二甲酸酯類 物質(Phthalates),多因具生殖毒性或潛在健康風險而被列入SVHC,為企業在產品合規管理中的重點關注項目。

如我們上週發布的第一篇所提及,在清單內的鄰苯類物質,屬 hashtag #低碳鏈鄰苯可塑劑 (LMW-Phthalates);而 hashtag #高碳鏈鄰苯可塑劑 (HMW- Phthalates),如 DINP、DIDP、DPHP等,因分子量較高且不具毒性特徵,被視為低風險的替代方案。

#聯成 洞察市場趨勢並緊密掌握國際法規動態,致力提供高品質且更安全的材料解決方案,與全球夥伴共創永續價值。

本文作者:
吳遵承博士 | 集團研發中心 | 研發主管

Solutions to reduce material volatility characteristics    is a food preservation product made from polyvinyl chloride (...
07/04/2026

Solutions to reduce material volatility characteristics

is a food preservation product made from polyvinyl chloride (PVC) as raw material, with high transparency and good extensibility, suitable for packaging fresh ingredients such as vegetables and fruits. (Di (2-ethylhexanol) Adipate, also known as ) is often added to PVC cling film. DEHA plasticizer is prone to volatilization and would generate excessive smoke during processing of cling film, posing a certain risk to the occupational health of workers; During the use of cling film, DEHA is prone to volatilization and migration, posing potential hazards to users.

To address the issues mentioned above, one of the plasticizer raw materials can be switched from to , upgrading DEHA to another plasticizer: (Diisononyl Adipate). In comparison, the volatility of this plasticizer is reduced by 57%, while the volatility of its applicants (e.g., PVC cling film for food) is reduced by 65%.
(The relevant volatility data is shown in the photo.)

Author
Yang Kong | Supervisor | Zhenjiang RD Center

Managing Editor
August Chang | Public Relations | Group Headquarters

食品接觸材料-降低材料揮發特性的解決方案

PVC #保鮮膜 是以 #聚氯乙烯 (PVC)為原料製成的食品保鮮用品,其特性透明度高、延展性好,適合包裝蔬菜水果等生鮮食材。 常規PVC保鮮膜中常常會添加可塑劑DEHA(己二酸二(2乙基己醇)酯,也被稱為DOA)。DEHA可塑劑容易揮發,在保鮮膜生產加工過程中容易產生過多煙氣,對工人的職業健康有一定危害;在保鮮膜使用過程中DEHA容易因使用環境的變化揮發遷移,對使用者存在潛在危害。

為解決以上問題,可以將可塑劑原料之一的醇類,從2EH換成INA,將DEHA升級為另一款可塑劑:DINA(己二酸二異壬酯)。相比之下,這款可塑劑的揮發性降低了57%,下游製品(如食品保鮮膜)的揮發性則降低65%,相關揮發資料如下圖:

本文作者
孔陽 | 鎮江研發中心 | 研發主管

責任編輯
張嘉麟 | 集團總部 | 公關

EU REACH: Phthalate Restrictions & Plastics Industry Transition  are essential for enhancing the flexibility and process...
02/04/2026

EU REACH: Phthalate Restrictions & Plastics Industry Transition

are essential for enhancing the flexibility and processability of . Research has indicated that certain chemicals may pose negative impacts on human health and the environment, prompting the global market to establish stringent regulations and driving the industry to seek safer alternatives.

1. Understanding &
REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) mandates that industry manages the risks of chemical substances to protect human health and the environment.
• SVHC (Substance of Very High Concern) Candidate List:
The primary mechanism for managing high-risk substances. The European Chemicals Agency (ECHA) updates this list twice a year.

2. Current Restrictions
( ) Phthalates (e.g., , , , ) are classified as high-risk substances. Their total concentration in plasticized materials is strictly capped at < 0.1% by weight.

3. Strategic Alternatives for Compliance
To maintain market competitiveness, companies should transition toward these proven technical paths:
• ( ) Phthalates (e.g., , , ): Recognized as lower-risk alternatives due to their safety profile. Restrictions apply only to toys and childcare articles that can be placed in the mouth (total concentration < 0.1%).
• (e.g., ): Utilizes advanced hydrogenation to convert benzene rings into saturated cyclohexane rings. This structural change offers an exceptional toxicological profile, making it the gold standard for sensitive applications like medical devices and infant products.

Author: Nick Tsai | Senior Engineer | QC Section, Kaohsiung RD Center

歐盟REACH規範:可塑劑的限制趨勢與塑膠產業轉型

在現代塑膠工業中, #可塑劑 能賦予 #聚氯乙烯 (PVC)優良的柔軟性與加工性能。研究指出部分化學品可能對人類環境造成負面影響,而促使全球市場制定嚴格法規,驅動產業尋求更安全的替代品。

一、 關於歐盟REACH法規
REACH是歐盟法規《化學品註冊、評估、授權和限制》的縮寫,旨在保護人類健康與環境,並要求企業承擔管理化學品風險的責任。其中,「高度關注物質」(SVHC)候選清單是管理具潛在重大風險物質的第一步。隨著REACH的實施進展,ECHA(歐洲化學署)每年會公佈新增的SVHC清單。

二、 現行對 #鄰苯 化學品的限制
目前幾項鄰苯二甲酸酯類化學品被列入SVHC候選清單,其中 #低碳鏈鄰苯(LMW-Phthalates)如DEHP、DBP、BBP、DIBP等,因具有較高的危害風險,被限制在成品塑化材料中的總含量不得超過0.1%。

三、安全的可塑劑替代方案
為接軌長遠環保趨勢並提升國際競爭力,建議採取以下產品替代可行方案:
1. #高碳鏈鄰苯 可塑劑(HMW- Phthalates):如 DINP、DIDP、DPHP等,因其分子量較高且不具毒性特徵,被視為低風險替代方案。僅因考量兒童暴露風險,針對可放入口中的玩具及照護用品用途採取預防性措施,要求DINP、DIDP 與 DNOP的總含量需低於0.1%,而DPHP則無此限制。
2. #無苯氫化可塑劑(DINCH):透過先進的氫化技術,將鄰苯二甲酸酯的苯環結構轉化為飽和的環己烷環。此結構性的本質改變,在毒理學評估中展現出極高的安全性,使其成為對安全性要求高的醫療及兒童玩具等產品的理想可塑劑選擇。

本文作者:蔡旻宏 | 高雄研發中心 品管 | 工程師

Address

南港路一段209號A棟9樓
Taipei
115

Opening Hours

Monday 08:30 - 17:30
Tuesday 08:30 - 17:30
Wednesday 08:30 - 17:30
Thursday 08:30 - 17:30
Friday 08:30 - 17:30

Alerts

Be the first to know and let us send you an email when 聯成化科 UPC Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to 聯成化科 UPC Technology:

Share